Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

53.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.5K
RNA Splicing01:32

RNA Splicing

15.9K
15.9K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

5.6K
5.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

20.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.2K
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.7K
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal assessment of cytotoxicity and cytomorphological changes in buccal mucosa exposed to dental laboratory chemicals.

Journal of Indian Prosthodontic Society·2026
Same author

Folic Acid-Guided PLGA-Zein Core-Shell Nanoparticles for Co-Delivery of Temozolomide and Ellagic Acid to Overcome PARP-Mediated Chemoresistance in Glioblastoma.

Pharmaceutics·2026
Same author

Macrophage-derived long non-coding RNAs in cancer: pioneering targets for immune modulation and personalized therapy.

Frontiers in immunology·2026
Same author

Novel PVA/collagen composite films loaded with 2-hydroxychalcones for controlled drug delivery and biomedical applications.

International journal of biological macromolecules·2026
Same author

Comparative <i>in vitro</i> study of <i>Coleus amboinicus</i> and paclitaxel on oral cancer cells.

Journal of oral and maxillofacial pathology : JOMFP·2026
Same author

Cytocompatibility of calcium hydroxide medicament combined with cationic peptide - An <i>in vitro</i> study on L929 fibroblast cells.

Journal of conservative dentistry and endodontics·2026

Related Experiment Video

Updated: May 6, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

2.6K

Splicing: A New Dimension in Decoding the Complex Traits for Cervical Cancer.

Varsha Sai B1, Ashwini Prabhu2,3, Ratnacaram Chandrahas Koumar2,3

  • 1Department of Molecular Medicine, JAIN (Deemed to be) University, Bangalore, India.

Current Cancer Drug Targets
|May 5, 2026
PubMed
Summary

Alternative splicing events generate diverse protein isoforms that influence cervical cancer development and spread. Identifying splicing factors offers new diagnostic and therapeutic strategies for this global health challenge.

Keywords:
Cervical cancerclinical responsegene regulationprognosissplicing

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

16.1K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

8.3K

Related Experiment Videos

Last Updated: May 6, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

2.6K
Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

16.1K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

8.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cervical cancer remains a significant global health issue, particularly in developing nations.
  • Complex etiological factors, including genetic and environmental influences, drive cervical cancer progression.
  • Understanding RNA splicing advances our knowledge of these complexities and offers new research avenues.

Purpose of the Study:

  • To elucidate how alternative splicing events contribute to cervical cancer.
  • To identify splicing factors as potential biomarkers for cervical cancer.
  • To explore the role of splicing in tumorigenesis, progression, and metastasis.

Main Methods:

  • A comprehensive literature search of PubMed and Google Scholar (2000-2024) was conducted.
  • Keywords included "splicing," "splicing factors," "gene regulation," "spliceosomes," "splicing as cancer hallmark," "splicing mechanisms," and "cervical cancer."
  • English-language publications specifically on splicing in cervical cancer were included.

Main Results:

  • Major splicing factors involved in cervical cancer were identified from genomic, clinical, and mechanistic studies.
  • These splicing factors show potential as significant prognostic and diagnostic biomarkers.
  • Alternative splicing contributes to the synthesis of diverse protein isoforms affecting cancer progression.

Conclusions:

  • Splicing mechanisms have a significant impact on clinical decision-making and therapeutic strategies for cervical cancer.
  • Targeting splicing offers potential for novel interventions and personalized medicine approaches.
  • Further research into splicing could improve clinical outcomes for cervical cancer patients.